TrialNeurology2021

Mexiletine in Myotonic Dystrophy Type 1: A Randomized, Double-Blind, Placebo-Controlled Trial.

Chad Heatwole et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.